Objective: Evidence from both laboratory and observational studies suggests that acute and chronic smoking leads to reduced highfrequency heart rate variability (HF-HRV), a measure of cardiac vagal regulation. We used ecological momentary assessment (EMA) to study the effect of smoking on concurrent HF-HRV in a trial measuring the effects of hostility reduction and compared 24-hour HF-HRV in smokers and nonsmokers. Conclusions: In healthy smokers with high hostility levels used as their own controls during daily living, smoking acutely reduced HF-HRV. HF-HRV was also reduced in smokers as compared with nonsmokers. Although limited by a small sample of individuals with high hostility levels, these findings nonetheless provide additional evidence that cardiac vagal regulation is lowered by cigarette smoking, which may be one of the numerous pathophysiological effects of smoking.
INTRODUCTION C
igarette smoking is associated with negative cardiovascular health effects and is one of the strongest risk factors for cardiovascular disease (CVD), stroke, peripheral vascular disease, and congestive heart failure (1) . CVD complications such as myocardial infarction and sudden cardiac death have also been associated with active cigarette smoking (2, 3) . Chronic cigarette smokers have an increased incidence of coronary artery spasm due to the vasoconstrictive effect that long-term cigarette smoking has on the coronary system (2) . Long-term smoking has a harmful impact on blood pressure and sympathetic tone, as well as reducing myocardial oxygenation (4) .
High-frequency heart rate variability (HF-HRV), a measure of cardiac vagal control, is positively correlated with healthy cardiac function and longevity (5) , whereas low HF-HRV predicts increased risk for all-cause mortality (6,7) and mortality after a fatal myocardial infarction (8, 9) . Several observational studies have reported the effects of chronic cigarette smoking on HRV in heavy smokers. Hayano et al. (10) found that heavy smokers have lower vagal activation, assessed by HRV, than nonsmokers. Barutcu et al. (11) found reduced time domain parameters of HRV (SD of normal to normal intervals and root mean squared successive differences) in heavy smokers when compared with nonsmokers.
Studies contrasting smokers and nonsmokers have produced sometimes contrasting findings. For example, Eryonucu et al. (12) reported that more global time domain indices of HRV were lower in smokers compared with nonsmokers but that there were no differences in heart rate or root mean square of successive differences in RR intervals (RMSSD), a time domain index of HF-HRV. In contrast, Alyan et al. (13) found that low-frequency (LF) power and the LF/HF ratio were greater in smokers compared with nonsmokers but HF power and standard deviation of normal-normal BMI = body mass index, CHD = coronary heart disease, CVD = cardiovascular disease, ECG = electrocardiogram, EMA = ecological momentary assessment, HF = high frequency, HRV = heart rate variability, LF = low frequency, PDA = personal digital assistant, PM 2.5 = particular matter of the size 2.5 microns, RMSSD = root mean square of successive differences in RR intervals, RRI = RR interval, SAS = statistical analysis system, SD = standard deviation RR intervals and RMSSD were lower in smokers. Kupari et al. (14) studied the effect of cigarette smoking on short-term HRV in a population free of heart disease and found that smoking was associated with a reduction of HRV. Molgaard et al. (15) studied the effect of smoking in healthy participants, comparing heavy smokers, moderate smokers, and nonsmokers, and found that smokers had lower total HRV during the daytime but not at nighttime. Lucini et al. (16) compared HRV in 20 heavy cigarette smokers and 20 nonsmoking volunteers of similar age and found significantly lower HF-HRV in the smokers, both when standing and at rest.
The acute effects of smoking on HRV have mainly been examined in laboratory studies. Hayano et al. (10) measured HRV parameters in smokers before smoking a cigarette and at different short-time intervals (3, 10, 17 , and 24 minutes) thereafter. They found a significant suppression of cardiac vagal control, reflected by reduced HF-HRV, 3 minutes after smoking the cigarette. Similarly, other laboratory studies have shown reduced parasympathetic activity associated with active smoking (17, 18) .
Both laboratory-based and observational cross-sectional studies have several limitations when studying the effect of acute and chronic cigarette smoking on HRV. Observational epidemiological studies are limited by possible selection biases and also limited by their cross-sectional approach. Laboratory studies are limited by their lack of ecological validity.
We are aware of only a single, small study examining withinperson relationships between cigarette smoking and HF-HRV in a natural living environment. Kobayashi et al. (19) studied the acute effect of cigarette smoking on HRV in a study population of 20 taxi drivers during a working day. In that study, HF-HRV tended to decrease within 5 minutes of cigarette smoking and recover within 15 minutes, and these changes differed between daytime and nighttime (19) . However, this study included only a small sample of smokers with no nonsmokers, monitored only for 12 hours, and did not control for physical position in the statistical analysis. Here, we used ecological momentary assessment (EMA) to sample multiple periods in the real-life environment, with concurrent ambulatory 24-hour electrocardiogram (ECG) monitoring to determine the effect of cigarette smoking on HF-HRV.
MATERIALS AND METHODS

Study Design
This is a secondary analysis of data from a randomized, controlled intervention trial of cognitive behavioral therapy treatment of hostility (20) . Data were collected between 2000 and 2005. Before randomization, we collected 24-hour ambulatory ECG recordings for all individuals; during this 24-hour period, individuals completed electronic diary entries, using a preprogrammed Palm Pilot personal digital assistant (PDA) time synchronized with the ECG recording, which prompted diary entries approximately every 30 minutes throughout the period of 10:30 AM to 10:30 PM. Diary entries provided EMA reports of physical position, medication use, caffeine consumption, alcohol consumption, and cigarette smoking during waking hours. Participants were designated as either smokers or nonsmokers, based on their EMA responses during the 24-hour monitoring period, that is, those who responded affirmatively to any prompt asking about smoking in the previous 30-minute period were designated as "smokers." Within smokers, we compared HRV in the period after smoking with HRV after nonsmoking periods. Between smokers and nonsmokers, we compared mean HRV over the course of the day.
Study Participants
Eligibility and exclusion criteria have been previously described (20) . Briefly, participants were recruited from the New York City area via print and radio advertisements to participate in a cognitive behavioral hostility and anger treatment study. Eligible participants were 20 to 45 years old, had a body mass index (BMI) of 32 kg/m 2 or less, and had no medical condition affecting the autonomic nervous system or cardiovascular system, no affective disorder, no psychosis, no substance abuse, and were not currently taking any psychoactive medication. In addition, eligibility required scores more than one SD above the population normative means on the 50-point Cook Medley Hostility Scale (21) (i.e., ≥26) and on the 30-point trait anger scale of the Spielberger State-Trait Anger Expression Inventory (22) (i.e., ≥25).
Study Protocol
Before randomization, participants wore a Marquette 8500 Holter ECG recorder attached to two ECG leads (CM2 and CM5), used to record the ECG signal during daily living activities for 24 hours. During this period, participants were provided with a PDA used as an electronic diary for EMA sampling.
Measurement of Smoking Events
During the 24-hour ECG monitoring period, the participants completed 12 hours of EMA using a PDA programmed to prompt them to complete a survey every 30 (5) minutes between the hours of 10:30 AM and 10:30 PM. The EMA survey questions used in this study are shown in Table 1 and included assessment of cigarettes smoked since last prompt (yes or no) and description of current physical posture. Missed prompts were followed by a reminder 5 minutes after the original prompt, after which the device went silent until the next prescheduled prompt.
Measurements of Outcome Variables
The ambulatory ECG recording was evaluated using a Marquette 8000 ECG or MARS scanner and then submitted to Marquette algorithms for initial QRS labeling and editing, resulting in an RR interval (RRI) time series. Errors not detected by Marquette editing were corrected using editing algorithms developed at Columbia University (23, 24) . The outcome variables were computed for the 5-minute epochs of RR intervals 
Statistical Analyses
A multilevel mixed model was estimated to generate maximum likelihood estimates of the difference in mean ln HF-HRV between smokers and nonsmokers and the mean within-person change in ln HF-HRV when smoking (compared with when not smoking) among smokers, adjusting for potential person-level and momentary confounders. Secondary analyses used the same modeling approach to estimate the effects of smoking status (difference between smokers and nonsmokers) and momentary smoking (current smoking versus not) on RMSSD and RRI for the 5-minute epoch preceding the EMA report, as follows:
Outcome it = α i + β where i indexes individuals and t indexes time.
The fact that parameters α and β 4 have subscripts "i" indicates that these are treated as random effects; for example, the model allows for the intercept and the momentary effect of smoking on the outcome to be different for each individual. The Momentary Smoking measure was person centered so that the coefficient of smoking status, β 1 , equals the difference between smokers (averaged over occasions when they smoked and when they did not) and nonsmokers on the outcome, adjusting for covariates. The mean level of β 4i provides an estimate of the average (across persons) momentary effect of smoking.
The within-person error term, ε it , allowed for unmeasured autocorrelation in the outcome, fitting a quasi-simplex error structure (27) taking into account the nonconstant time intervals between assessments. Specifically, the error structure is made up of two components, one conforming to a first-order serial autocorrelation structure with varying time intervals between observations and the other exhibiting no autocorrelation; the latter could be interpreted as "measurement error," consistent with the "error" component of Kenny and Zautra's (28) trait-state-error model (the trait component is captured by the α i ).
For all estimated parameters, a p value less than .05 was considered to be statistically significant. All analyses were performed using mixed modeling software (SAS 9.3; Proc Mixed). This analytic approach was described in detail in the study by Schwartz and Stone (29) .
Institutional Review
This study, as well as the original study protocol, was approved by the institutional review board of Columbia University Medical Center. All participants provided informed consent before participating in the study.
RESULTS
Demographics
Thirty-five smokers and 114 nonsmokers provided EMA and HRV data for 5067 periods. The sample (N = 149) was 47% male, and the average SD age and BMI were 30.8 (6.8) years and 23.7 (3.7) kg/m 2 , respectively. Table 2 shows the baseline demographics by smoking status in the sample. Most smokers were male, whereas most nonsmokers were female (p = .02 by Fisher exact test). Neither age nor BMI differed significantly by smoking status.
RR Interval and HRV in Smokers During Smoking and Nonsmoking Periods
Among the 35 smokers, there were 259 episodes of smoking during the monitoring days. Within smokers, there were significant effects of smoking on RRI and HF-HRV: RRI after a smoking event was lower than for nonsmoking periods (711.4 versus 740.8 milliseconds, difference = −29.4 milliseconds, p < .001), and ln HF-HRV was reduced after smoking when compared with periods of not smoking (5.09 versus 5.40, difference = −0.31 milliseconds 2 , p = .04). The scale-free measure of HF-HRV, computed to control for the dependency of HRV on mean HR (28), also was reduced after smoking (difference = −0.24, p = .06). The effect of smoking on RMSSD was marginally significant (p = .06). The within-person effects of cigarette smoking on HRV and RRI are shown in Table 3 .
24-Hour HRV in Smokers Versus Nonsmokers
Averaged across all periods, M (SD) RRI SD was 725.85 (13.17) milliseconds for smokers and 768.88 (7.18) milliseconds for β smoking = unstandardized regression coefficient estimating, for smokers, the difference in HRV between periods when they smoked and periods when they did not; CI = confidence interval; RRI = RR interval; Ln HF-HRV = natural logarithm highfrequency heart rate variability; RMSSD = the root mean square of successive differences in beat-to-beat RR interval.
The estimates listed here come from a mixed model that statistically controls for (physical position, medication use, caffeine consumption, alcohol consumption, and cigarette smoking) during waking hours. 
DISCUSSION
We found that among smokers, smoking episodes during daily living were associated with a reduced HF-HRV compared with nonsmoking episodes, supporting our hypothesis that smoking is associated with reduced cardiac vagal regulation on a momentto-moment basis. The within-person effect of cigarette smoking on RMSSD achieved marginal significance (p < .06). Correspondingly, between-person comparisons revealed reduced average HF-HRV among smokers (pooled across periods of smoking and nonsmoking) when compared with the nonsmokers, averaged across all periods, as predicted. This finding supports our prediction that HF-HRV is lower among smokers when compared with nonsmokers. RMSSD among smokers, averaged across all periods, was marginally lower when compared with nonsmokers. Adjusting for mean RRI marginally attenuated these findings.
The findings of this study suggest that HF-HRV, a frequency domain measure and an index of cardiac vagal regulation, was reduced within the smokers, when smoking during daily living. This is consistent with previous literature indicating that both frequency and time domain measures of HRV are reduced among smokers when compared with nonsmokers (10, 11, 30) . Both the results obtained from the within-person analysis of cigarette smoking and from the cross-sectional comparison between smokers and nonsmokers participating in this study are consistent with previous studies showing that acute and chronic smoking are associated with reduced HRV (10, 17, 18) .
There are, however, some possible inconsistencies between our findings and those of Hayano et al. (10) and Kobayashi et al. (19) .
Both of these studies found that cigarette smoking caused an acute reduction in HF-HRV at 3 to 5 minutes after smoking, with HF power returning to baseline by 10 minutes. Our diary asked only whether participants had smoked within the last 30 minutes. Therefore, we cannot determine precisely when within this 30-minute window the cigarette smoking occurred and what the time course of recovery was. Moreover, other methodological differences make these comparisons difficult. Hayano et al. rigorously controlled exposure to cigarette smoking in a laboratory setting, with individuals smoking 4 cm of a cigarette containing 1.0 mg of nicotine for a 2-minute period while in the supine position. In contrast, as field studies, we and Kobayashi et al. (19) allowed individuals to smoke ad libitum, smoking as frequently and as completely as they chose while in the seated position.
Although there are multiple components of cigarette smoke, it is likely that the effects on cardiovascular autonomic regulation involve nicotine. For example, a 4-mg dose of oral nicotine reduces HF-HRV in nonsmokers, indicating that nicotine itself leads to reduced vagal regulation (31) . Environmental exposure to nicotine, measured in a commercial airport, was also associated with reduced HF-HRV (32) .
Cigarette smoke stimulates the release of catecholamines through effects on nicotinic cholinergic receptors in peripheral postganglionic sympathetic nerve endings and the adrenal medulla (33) . This nicotine-induced release of catecholamines is associated with both acute and chronic cardiovascular events such as cardiac rhythm disorders (5, 18) . A previous animal study showed that the perfusion of nicotine to the sinoatrial node in dogs leads to both a cholinergically mediated slowing of the heart and a nonreaction of the heart to electrical stimulation of the cervical vagus for more than 5 minutes. This nonreaction of the heart to vagal stimulation corresponds to the ganglionic blocking effect of nicotine, also manifested by cigarette smoking in humans (34) .
The fine particular matter of the size 2.5 microns (PM2.5) are particles that have a size to reach deep into the respiratory tract and are therefore often measured by health authorities as an index of general air pollution. Liao et al. (35) invited 26 volunteer elderly to a 21-day study of ECG monitoring and continuous measurement of PM2.5. They found that lower autonomic control was significantly associated with higher levels of PM2.5 indoors as well as outdoors (35) . Since PM2.5 is also a component of tobacco smoke, in addition to the nicotine pathway, this may be a mechanism for the vagal down-regulation we have found in smokers.
Our findings may contribute to an understanding of the interrelationships of hostility and smoking in the pathogenesis of coronary artery disease. There is substantial evidence that cigarette smoking and reduced HRVare, both separately and in combination, associated with an increased risk for developing cardiac disease (1, 36) . A recent meta-analysis concluded that hostile behavior is associated with increased coronary heart disease (CHD) events both in healthy populations and in populations with already diagnosed CHD (37) . However, the authors found that the harmful effects of hostility on CHD were no longer significant in either population after adjusting for smoking. Nonetheless, Wong et al. (38) studied the possible mechanisms responsible for the association between hostility and cardiovascular events in a large sample of patients with CHD. The authors concluded RRI = RR interval; M (SD) = mean (standard deviation); Ln HF-HRV = natural logarithm high-frequency heart rate variability; RMSSD = the root mean square of successive differences in beat-to-beat RR interval.
This table shows the least square means for the nonsmoker and the smoker group and the p value represents the difference between these two groups. The estimates listed here come from a mixed model that statistically controls for (physical position, medication use, caffeine consumption, alcohol consumption, and cigarette smoking) during waking hours.
that a large part of the association is attributed to specific poor health behaviors such as physical inactivity and smoking (38) . We have previously demonstrated that hostility is inversely related to parasympathetic cardiac control, reflected by reduced HF-HRV in a young, healthy population. That finding and the findings of this study may suggest that altered autonomic regulation could be a pathogenic mechanism linking high hostility levels and a higher risk of developing coronary artery disease (39) . We are not aware of any previous studies looking at the within-person effect of cigarette smoking on HF-HRV within a hostile population. Our findings suggest that smoking events further depress parasympathetic cardiovascular regulation in hostile individuals, which may transiently heighten their vulnerability to acute cardiac events.
Strengths
A strength of this study is the collection of multiple ecologically valid date/time-stamped diary entries that enabled within-person analyses. Diary entries of smoking assessed in real time decrease the likelihood of error in participants' recollections of smoking frequency. In addition, continuous ECG recording allowed HF-HRV to be quantified for specific periods just before each EMA report. The use of PDAs reduced the risk of data loss.
Limitations
This study was limited by its relatively small sample size of 149 participants (35 smokers and 114 nonsmokers). Individuals with high hostility levels were selected, which may limit generalizability of the findings. Further application of this data collection and analytic approach to larger, normative samples could yield further insight into the effects of smoking on HRV in everyday life. Finally, there was substantial dropout in the study.
CONCLUSIONS
Both the within-person effect of cigarette smoking and the effect of smoking status are associated with reduced HF-HRV. They suggest that cardiac vagal regulation is lowered by cigarette smoking, which may be one of the many pathophysiological effects by which smoking increases cardiovascular risk. This study demonstrates that HF-HRV is transiently decreased after each episode of smoking in daily life with EMA. This strongly suggests that each and every cigarette smoked is a transient risk factor for untoward events related to transiently lowered parasympathetic cardiac effects. Future studies should examine whether these HRV changes mediate the effect of cigarette smoking on the risk of harmful cardiovascular events.
